Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol

por Tsai, Max, Case, Michael, Ardayfio, Paul, Hochstetler, Helen, Wilbraham, Darren
Publicado 2020

Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults

por Trzepacz, Paula T., Hochstetler, Helen, Wang, Shufang, Walker, Brett, Saykin, Andrew J.
Publicado 2015

Lasmiditan mechanism of action – review of a selective 5-HT(1F) agonist

por Clemow, David B., Johnson, Kirk W., Hochstetler, Helen M., Ossipov, Michael H., Hake, Ann M., Blumenfeld, Andrew M.
Publicado 2020

Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, ph...

por Shapiro, Robert E., Hochstetler, Helen M., Dennehy, Ellen B., Khanna, Rashna, Doty, Erin Gautier, Berg, Paul H., Starling, Amaal J.
Publicado 2019

Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline

por Hochstetler, Helen, Trzepacz, Paula T., Wang, Shufang, Yu, Peng, Case, Michael, Henley, David B., Degenhardt, Elisabeth, Leoutsakos, Jeannie-Marie, Lyketsos, Constantine G.
Publicado 2015

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations

por Witte, Michael M., Foster, Norman L., Fleisher, Adam S., Williams, Monique M., Quaid, Kimberly, Wasserman, Michael, Hunt, Gail, Roberts, J. Scott, Rabinovici, Gil D., Levenson, James L., Hake, Ann Marie, Hunter, Craig A., Van Campen, Luann E., Pontecorvo, Michael J., Hochstetler, Helen M., Tabas, Linda B., Trzepacz, Paula T.
Publicado 2015